Patent details

EP2272869 Title: Angiopoietin-2 specific binding agents

Basic Information

Publication number:
EP2272869
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP100116516
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Angiopoietin-2 specific binding agents
French Title of Invention:
Agents de liaison spécifiques à l'angiopoietin-2
German Title of Invention:
Angiopoietin-2-spezifische Bindungsmittel
SPC Number:

Dates

Filing date:
11/10/2002
Grant date:
20/11/2013
EP Publication Date:
20/11/2013
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
12/01/2011
EP B1 Publication Date:
20/11/2013
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
11/10/2014
Expiration date:
11/10/2022
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
11/10/2002
 
 

Name:
Amgen Inc.
Address:
One Amgen Center Drive, Thousand Oaks, CA 91320-1799, United States (US)

Inventor

Name:
Oliner Jonathan Daniel
Address:
United States (US)

Priority

1

Priority Number:
328604 P
Priority Date:
11/10/2001
Priority Country:
United States (US)

2

Priority Number:
269805
Priority Date:
10/10/2002
Priority Country:
United States (US)

Classification

Main IPC Class:
C07K 16/22;
Filing date Document type Number of pages